Credit Suisse’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $500M | Buy |
859,879
+45,128
| +6% | +$25.3M | 0.48% | 27 |
|
|
2023
Q4 | $432M | Buy |
814,751
+4,195
| +0.5% | +$2.03M | 0.42% | 35 |
|
|
2023
Q3 | $410M | Buy |
810,556
+24,125
| +3% | +$12.9M | 0.42% | 39 |
|
|
2023
Q2 | $410M | Sell |
786,431
-236,192
| -23% | -$127M | 0.41% | 36 |
|
|
2023
Q1 | $589M | Sell |
1,022,623
-108,971
| -10% | -$61.4M | 0.59% | 25 |
|
|
2022
Q4 | $623M | Buy |
1,131,594
+75,118
| +7% | +$39.8M | 0.66% | 19 |
|
|
2022
Q3 | $536M | Sell |
1,056,476
-72,157
| -6% | -$40.4M | 0.6% | 23 |
|
|
2022
Q2 | $613M | Sell |
1,128,633
-78,412
| -6% | -$43.2M | 0.64% | 22 |
|
|
2022
Q1 | $713M | Buy |
1,207,045
+78,269
| +7% | +$45M | 0.61% | 19 |
|
|
2021
Q4 | $753M | Sell |
1,128,776
-56,934
| -5% | -$35.5M | 0.4% | 38 |
|
|
2021
Q3 | $677M | Buy |
1,185,710
+43,761
| +4% | +$24M | 0.37% | 42 |
|
|
2021
Q2 | $580M | Sell |
1,141,949
-560,791
| -33% | -$265M | 0.31% | 45 |
|
|
2021
Q1 | $777M | Buy |
1,702,740
+260,165
| +18% | +$124M | 0.4% | 38 |
|
|
2020
Q4 | $672M | Buy |
1,442,575
+104,695
| +8% | +$49.1M | 0.33% | 49 |
|
|
2020
Q3 | $591M | Buy |
1,337,880
+445,305
| +50% | +$184M | 0.36% | 42 |
|
|
2020
Q2 | $323M | Buy |
892,575
+82,989
| +10% | +$27.8M | 0.23% | 80 |
|
|
2020
Q1 | $230M | Sell |
809,586
-26,823
| -3% | -$8.46M | 0.2% | 97 |
|
|
2019
Q4 | $272M | Buy |
836,409
+111,547
| +15% | +$33.8M | 0.2% | 83 |
|
|
2019
Q3 | $211M | Buy |
724,862
+14,760
| +2% | +$4.23M | 0.18% | 98 |
|
|
2019
Q2 | $209M | Sell |
710,102
-11,834
| -2% | -$3.26M | 0.18% | 98 |
|
|
2019
Q1 | $198M | Sell |
721,936
-48,812
| -6% | -$12.1M | 0.18% | 89 |
|
|
2018
Q4 | $172M | Sell |
770,748
-195,945
| -20% | -$46M | 0.18% | 97 |
|
|
2018
Q3 | $236M | Buy |
966,693
+45,029
| +5% | +$10.4M | 0.21% | 74 |
|
|
2018
Q2 | $191M | Sell |
921,664
-92,429
| -9% | -$19.6M | 0.19% | 91 |
|
|
2018
Q1 | $209M | Buy |
1,014,093
+133,757
| +15% | +$28.1M | 0.2% | 85 |
|
|
2017
Q4 | $167M | Buy |
880,336
+36,058
| +4% | +$6.91M | 0.15% | 119 |
|
|
2017
Q3 | $160M | Buy |
844,278
+82,912
| +11% | +$15M | 0.16% | 118 |
|
|
2017
Q2 | $133M | Buy |
761,366
+42,354
| +6% | +$7.11M | 0.13% | 143 |
|
|
2017
Q1 | $110M | Sell |
719,012
-19,316
| -3% | -$2.95M | 0.1% | 203 |
|
|
2016
Q4 | $104M | Sell |
738,328
-62,744
| -8% | -$9.25M | 0.1% | 193 |
|
|
2016
Q3 | $127M | Buy |
801,072
+48,274
| +6% | +$7.44M | 0.12% | 150 |
|
|
2016
Q2 | $111M | Buy |
752,798
+89,284
| +13% | +$13.2M | 0.12% | 160 |
|
|
2016
Q1 | $93.9M | Sell |
663,514
-49,119
| -7% | -$6.58M | 0.11% | 189 |
|
|
2015
Q4 | $101M | Buy |
712,633
+113,569
| +19% | +$15.1M | 0.12% | 175 |
|
|
2015
Q3 | $73.3M | Sell |
599,064
-30,035
| -5% | -$3.91M | 0.09% | 245 |
|
|
2015
Q2 | $81.6M | Sell |
629,099
-189,883
| -23% | -$24.8M | 0.08% | 256 |
|
|
2015
Q1 | $110M | Sell |
818,982
-104,838
| -11% | -$13.5M | 0.11% | 194 |
|
|
2014
Q4 | $116M | Sell |
923,820
-121,709
| -12% | -$14.8M | 0.1% | 198 |
|
|
2014
Q3 | $127M | Buy |
1,045,529
+252,143
| +32% | +$30.7M | 0.1% | 193 |
|
|
2014
Q2 | $93.6M | Buy |
793,386
+37,924
| +5% | +$4.46M | 0.08% | 246 |
|
|
2014
Q1 | $90.8M | Sell |
755,462
-29,663
| -4% | -$3.53M | 0.09% | 217 |
|
|
2013
Q4 | $87.4M | Buy |
785,125
+151,353
| +24% | +$15M | 0.08% | 229 |
|
|
2013
Q3 | $58.4M | Sell |
633,772
-162,838
| -20% | -$14.7M | 0.06% | 298 |
|
|
2013
Q2 | $67.4M | Buy |
+796,610
| New | +$66.3M | 0.07% | 282 |
|
Other funds holding TMO
Credit Suisse's TMO Position: Q1 2024 in Review
Credit Suisse increased its Thermo Fisher Scientific (TMO) stake by 5.5% in Q1 2024, buying an estimated $25.3M and bringing the position to 859,879 shares worth $500M. The position accounts for 0.48% of the portfolio, ranked #27.
Credit Suisse first reported a position in TMO in Q2 2013 and has held it in 44 quarters since. The position peaked at $777M in Q1 2021. 2,527 funds tracked by Wall St. Rank hold TMO as of Q1 2024.
- Credit Suisse held 859,879 shares of Thermo Fisher Scientific worth $500M as of Q1 2024.
- Credit Suisse bought 45,128 Thermo Fisher Scientific shares in Q1 2024, an estimated $25.3M.
- Thermo Fisher Scientific made up 0.48% of Credit Suisse's portfolio in Q1 2024, its #27 holding.
- Credit Suisse first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 44 quarters since.
- Credit Suisse's Thermo Fisher Scientific position peaked at $777M in Q1 2021.
- 2,527 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.